The clinical management of BRCA1 and BRCA2 mutation carriers

@article{Gulati2006TheCM,
  title={The clinical management of BRCA1 and BRCA2 mutation carriers},
  author={A. P. Gulati and S. Domchek},
  journal={Current Oncology Reports},
  year={2006},
  volume={10},
  pages={47-53}
}
  • A. P. Gulati, S. Domchek
  • Published 2006
  • Medicine
  • Current Oncology Reports
  • Mutations in the cancer susceptibility genes BRCA1 and BRCA2 are associated with significantly increased risks of breast and ovarian cancer. Fortunately, effective strategies are available to reduce these risks, including genetic testing, which is an important consideration in determining management of patients with a strong family history of cancer. This article reviews the current evidence for risk-reducing strategies in BRCA1 and BRCA2 mutation carriers and outlines future research… CONTINUE READING
    9 Citations

    Topics from this paper

    Effective preventive treatments for hereditary breast cancer
    • Highly Influenced
    Mammographic parenchymal texture as an imaging marker of hormonal activity: a comparative study between pre- and post-menopausal women
    • 2
    • PDF
    Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain.
    • G. Giannini, C. Capalbo, +13 authors A. Gulino
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2008
    • 14

    References

    SHOWING 1-10 OF 56 REFERENCES
    Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
    • 648
    • PDF
    Cancer Susceptibility and the Functions of BRCA1 and BRCA2
    • 1,484
    • PDF
    Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    • T. Rebbeck, T. Friebel, +10 authors B. Weber
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2004
    • 666
    • PDF
    Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
    • 687
    The role of BRCA1 in the cellular response to chemotherapy.
    • 384
    • PDF
    Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
    • A. Eisen, J. Lubiński, +17 authors S. Narod
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2005
    • 438